High incidence of newly-developed gastroesophageal reflux disease in the Japanese community: A 6-year follow-up study

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 3, 2008, Pages 393-397

  Miyamoto, Masaki ^a   Haruma, Ken ^b   Kuwabara, Masao ^a   Nagano, Makoto ^b   Okamoto, Takeshi ^c   Tanaka, Mio ^d  

^a HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c Tottori Prefectural Cyuo Hospital   (Japan)

^d Soryo Municipal Clinic   (Japan)

Author keywords

Gastroesophageal reflux disease; Helicobacter pylori; Incidence; Pepsinogen; QUEST; Risk factor

Indexed keywords

CALCIUM ANTAGONIST; PEPSINOGEN; PEPSINOGEN I; PEPSINOGEN II;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ATROPHIC GASTRITIS; BLOOD SAMPLING; BODY MASS; CONSTIPATION; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; INCIDENCE; JAPAN; KYPHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS;

EID: 40349114884     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05043.x     Document Type: Article

References (29)

1. 1 Talley NJ, Boyce P, Jones M. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut 1998 ; 42: 690–5.
2. 2 Wang JH, Lou JY, Dong L, Gong J, Tong M. Epidemiology of gastroesophageal reflux disease: a general population‐based study in Xi'an of Northwest China. World J. Gastroenterol. 2004 ; 10: 1647–51.
3. 3 Papatheodoridis GV, Karamanolis DG. Prevalence and impact of upper and lower gastrointestinal symptoms in the Greek urban general population. Scand. J. Gastroenterol. 2005 ; 40: 412–21.
4. 4 Furukawa N, Iwakiri R, Koyama T et al. Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J. Gastroenterol. 1999 ; 34: 441–4.
5. 5 Carlsson R, Dent J, Bolling‐Stenevald E et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand. J. Gastronterol. 1998 ; 33: 1023–9.
6. 6 Haruma K, Hamada H, Mihara M et al. Negative association between Helicobacter pylori i nfection and reflux esophagitis in older patients: case‐control study in Japan. Helicobacter 2000 ; 5: 24–9.
7. 7 Asaka M, Kimura T, Kudo M et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992 ; 102: 760–6.
8. 8 Haruma K, Okamoto S, Kawaguchi H et al. Reduced incidence of Helicobacter pylori infection in young Japanese persons between 1970s and 1990s. J. Clin. Gastroenterol. 1997 ; 25: 583–6.
9. 9 Haruma K, Kamada T, Kawaguchi H et al. Effect of age and Helicobacter pylori infection on acid secretion. J. Gastroenterol. Hepatol. 2000 ; 15: 277–83.
10. 10 Haruma K. Influence of Helicobacter pylori on gastro‐oesophageal reflux disease in Japan. Aliment. Pharmacol. Ther. 2004 ; 20 (Suppl. 8): 40–4.
11. 11 Kinoshita Y, Kawanami C, Kishi K, Nakata H, Seino Y, Chiba T. Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut 1997 ; 41: 452–8.
12. 12 Okamoto K, Iwakiri R, Mori M et al. Clinical symptoms in endoscopic reflux esophagitis: evaluation in 8031 adult subjects. Dig. Dis. Sci. 2003 ; 48: 2237–41.
13. 13 Nagano K, Kubo M, Goto M et al. Diagnosis of GERD—Usefulness of OUEST questionnaire on patients with upper gastrointestinal symptoms. J. New Remedies Clin. 1998 ; 47: 169–79 (in Japanese).
14. 14 Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and development of gastric cancer. N. Engl. J. Med. 2001 ; 345: 784–9.
15. 15 Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum Pepsinogen I, serum Pepsinogen II, and gastric mucosal histology. Gastroenterology 1982 ; 83: 204–9.
16. 16 Miki K, Ichinose M, Shimizu A et al. Serum pepsinogen as a screening test of extensive chronic gastritis. Gastroenterol. Jpn. 1987 ; 22: 133–41.
17. 17 Haruma K, Yoshihara M, Sumii K et al. Gastric acid secretion, serum pepsinogen I, and serum gastrin in Japanese with gastric hyperplastic polyps or polypoid‐type early gastric carcinoma. Scand. J. Gastroenterol. 1993 ; 28: 633–7.
18. 18 Webb PM, Hengeles KJ, Moller H et al. The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group. Gastroenterology 1994 ; 107: 1335–44.
19. 19 Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am. J. Gastroenterol. 2003 ; 98: 735–9.
20. 20 Fujishiro M, Oka M, Yahagi N et al. Correlation of serum pepsinogens and gross appearances combined with histology in early gastric cancer. J. Exp. Clin. Cancer Res. 2006 ; 25: 207–12.
21. 21 Oishi Y, Kiyohara H, Kubo M et al. The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study. Am. J. Epidemiol. 2006 ; 163: 629–37.
22. 22 Isolauri L, Laippala P. Prevalence of symptoms suggestive of gastro‐oesophageal reflux disease in an adult population. Ann. Med. 1995 ; 27: 67–70.
23. 23 Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Risk factors associated with symptoms of gastroesophageal reflux. Am. J. Med. 1999 ; 106: 642–9.
24. 24 Fujimoto K, Iwakiri R, Okamoto K et al. Characteristics of gastroesophageal reflux disease in Japan: increased prevalence in elderly women. J. Gastroenterol. 2003 ; 38 (Suppl. 15): 3–6.
25. 25 Tagle Arrospide M, Aguinaga Mezz M, Vasquez Rubio G. Hiatal hernia as a risk factor for erosive esophagitis: experience and endoscopic findings of a Peruvian population with heartburn. Rev. Gastroenterol. Peru 2003 ; 23: 36–40.
26. 26 Labenz J, Jasersen D, Kulig M et al. Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am. J. Gastroenterol. 2004 ; 99: 1652–6.
27. 27 Johnson DA, Fennerty MB. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology 2004 ; 126: 660–4.
28. 28 Johnson DA. Gastroesophageal reflux disease in the elderly‐a prevalent and severe disease. Rev. Gastroenterol. Disord. 2004 ; 4: S16–24.
29. 29 Inamori M, Togawa J, Nagase H et al. Clinical characteristics of Japanese reflux esophagitis patients as determined by Los Angeles classification. J. Gastroenterol. Hepatol. 2003 ; 18: 172–6.